Regeneron's COVID antibody drug shows protection

Advertise with us

Advertise with us

QatarDay

Health & Wellbeing

Regeneron's COVID antibody drug

Regeneron's COVID antibody drug shows protection for up to 8 months

Regeneron Pharmaceuticals Inc (REGN.O) said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in a late-stage trial, in the two to eight months period following the drug's administration...

Desert Falls Live a Little — VIDEO OF THE WEEK

Follow US

categories